Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0030 Transporter Info | ||||
| Gene Name | SLCO1B3 | ||||
| Protein Name | Organic anion transporting polypeptide 1B3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs11045585 | ||||
| Site of GPD | chr12:20892760 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>G | ||||
| Minor Allele Frequency | G=0.1552/777 (Global) | ||||
| Allele G | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Docetaxel | Drug Info | Neoplasm | Correlated with the increased leukopenia risk in patients (compare with Allele A) | [ 1] | |
| Genetic Polymorphism | rs4149117 | ||||
| Site of GPD | chr12:20858546 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C / T>G | ||||
| Minor Allele Frequency | T=0.2975/1490 (Global) | ||||
| Allele G | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Mycophenolate mofetil | Drug Info | Kidney Transplantation | Correlated with the decreased dose-normalized Cmax and dose-normalized AUC0to12 h in patients (compare with Allele T); Correlated with the increased adverse drug reactions risk in patients (compare with Allele T); Irrelevant to the drug clearance in patients (compare with Allele T) | [ 2], [ 3] | |
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Mycophenolate mofetil | Drug Info | Kidney Transplantation | Irrelevant to the increased leukopenia risk in patients (compare with allele G) | [ 4] | |
| Genotype GG | Click to Show/Hide the Full List of Affected Drugs: 4 Drugs in Total | ||||
| Sunitinib | Drug Info | Gastrointestinal Stromal Tumors | Correlated with the decreased overall survival in patients (compare with Genotypes GT + TT) | [ 5] | |
| Paclitaxel | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased anemia risk in patients (compare with Genotypes GT + TT) | [ 6] | |
| Carboplatin | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased anemia risk in patients (compare with Genotypes GT + TT) | [ 6] | |
| Mycophenolate mofetil | Drug Info | Kidney Transplantation | Correlated with the increased dose-adjusted area under the curve of mycophenolic acid in patients (AUC6-12) (compare with Genotype TT) | [ 7] | |
| Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Mycophenolate mofetil | Drug Info | Kidney Transplantation | Correlated with the increased diarrhea risk in patients (compare with genotype GG); Correlated with the increased diarrhea risk in patients (compare with genotype Gt) | [ 4] | |
| Genotypes GT + TT | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Paclitaxel | Drug Info | Lung Neoplasm; Malignant Tumor Of Peritoneum; Ovarian Neoplasm; Uterine Neoplasm | Correlated with the decreased likelihood of thrombocytopenia in patients (compare with genotype GG) | [ 8] | |
| Carboplatin | Drug Info | Lung Neoplasm; Malignant Tumor Of Peritoneum; Ovarian Neoplasm; Uterine Neoplasm | Correlated with the decreased likelihood of thrombocytopenia in patients (compare with genotype GG) | [ 8] | |
| Genetic Polymorphism | rs7311358 | ||||
| Site of GPD | chr12:20862826 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A | ||||
| Minor Allele Frequency | G=0.2975/1490 (Global) | ||||
| Allele A | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Mycophenolate mofetil | Drug Info | Kidney Transplantation | Correlated with the decreased drug clearance in patients (compare with allele G); Irrelevant to the drug clearance in patients (compare with allele G) | [ 3] | |
| Paclitaxel | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the decreased transport of drug (compare with allele G) | [ 6] | |
| Genotype AA | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
| Paclitaxel | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased anemia risk in patients (compare with genotypes AG + GG) | [ 6] | |
| Carboplatin | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased anemia risk in patients (compare with genotypes AG + GG) | [ 6] | |
| Mycophenolate mofetil | Drug Info | Kidney Transplantation | Correlated with the increased dose-adjusted area under the curve (AUC6-12) of mycophenolic acid in patients (compare with genotype GG) | [ 7] | |
| References | |||||
| 1 | Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer Sci. 2008 May;99(5):967-72. | ||||
| 2 | SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients. Pharmacogenomics. 2010 Dec;11(12):1703-13. | ||||
| 3 | The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther. 2010 Jan;87(1):100-8. | ||||
| 4 | Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipients. Pharmacogenet Genomics. 2012 Jun;22(6):399-407. | ||||
| 5 | Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib. Pharmacogenomics J. 2018 Jan;18(1):49-55. | ||||
| 6 | Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy. Pharmacogenet Genomics. 2016 Mar;26(3):116-25. | ||||
| 7 | Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Eur J Clin Pharmacol. 2007 Dec;63(12):1161-9. | ||||
| 8 | Polymorphisms in SLCO1B3 and NR1I2 as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination. Pharmacogenomics. 2015;16(13):1439-50. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.